| Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that its current joint venture target, Amarantus BioSciences, Inc. (OTCBB: AMBS), has cited several new peer-reviewed articles detailing its new protein therapy MANF to its website, bringing the total to 20. A listing of the citations can be viewed on the company's website at www.amarantus.com/investor-relations/scientific-publications.html. The publications cited on Amarantus' ...continued RBCC |
Thursday, May 3, 2012
RBCC: Global Scientific Community Embraces New Parkinson's Therapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment